Clinical Trial Update: Prograf-Advagraf Cross Over Conversion Study [Phase 3]

View source ↗

Summary

Phase 3 cross-over conversion study comparing Prograf and Advagraf tacrolimus formulations in kidney-pancreas transplant recipients has completed. The trial eva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation
• Pancreatic Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Kidney-Pancreas Transplantation | Phase 3 | Status: COMPLETED